Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Breast cancer drugs drive sales at Roche

Country: Switzerland

The Roche group posted a sales gain of 5% to CHF 22,974 million (€18,905 million) in the first half, driven by a 30% rise in US revenue from its breast cancer medicines. The gains were in constant currencies; measured in Swiss francs there was a decline of 1%.

Read more

GSK sales and profit fall in Q2

Country: United Kingdom

GlaxoSmithKline Plc saw across-the-board declines in revenue and profit in the second quarter as competition increased in the US for its respiratory products and the consumer division was hit by supply interruptions for some medicines.

Read more

Update on the human embryo

Country: Luxembourg

Read more

Sobi increases revenue by 27%

Country: Sweden

Read more

AbbVie wins Shire for £32 billion

Country: United States

Read more

Novartis had modest Q2 sales gain

Country: Switzerland

Read more

GSK melanoma trial stopped early

Country: United Kingdom

Read more

Protein structure displayed

Country: United Kingdom

Read more

Dengue vaccine effective

Country: France

Read more

FDA approves Ruconest for HAE

Country: Netherlands

Read more

Immunocore to discover drugs with Lilly

Country: United Kingdom

Read more

Immatics completes Series D funding

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Gently pushing the accelerator in cancer by Frederic Triebel

FredericTriebel.pdf

Highlights of the July-Aug 2014 MedNous issue

The July-Aug 2014 MedNous features:

Latest Mednous cover
  • Business Strategy
    Why Big Pharma is
    seizing the orphan drug
    opportunity
  • Oncology
    Hitting the accelerator
    in immunotherapy
    By Frederic Triebel
  • Regulatory
    Next step for clinical trial
    transparency
  • Commentary
    Who has the lead in
    genomic research?
    By Florian Bazant-Hegemark
    and Gareth Williams
  • Markets
    Quarterly stock market review
    AbbVie wins Shire

The latest MedNous journal. Subscribe to download.